Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|2|247-253

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.2, 2015-10, pp. : 247-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 247-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment Options for Autoimmune Cytopenias

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 5, 2004-10 ,pp. : 332-340

Karger

Access to resources Recommend Favorite

Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : E47-E49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Revisiting mycophenolate mofetil for steroid‐refractory acute graft‐versus‐host disease: Is higher dosing effective in children?

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 582-583

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycophenolate mofetil for treatment of steroid‐refractory acute graft‐versus‐host disease after pediatric hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 652-658

John Wiley & Sons Inc

Access to resources Recommend Favorite